The Quiet Automation Wave Reshaping Life Sciences Labs
A biotech lab today doesn’t look much different from one five years ago. Same benches, same coats, same rows of plates. What’s changed is quieter than that. Fewer people are standing at those benches for hours at a stretch, dispensing the same volumes into the same wells, over and over. A machine does that now, […]
Novotech Strengthens Japan Presence with New Tokyo Office
Novotech, a leading global biotech CRO and full-service clinical research organization, has strengthened its established presence in Japan with the opening of a new office in Tokyo. The investment builds on Novotech’s existing operations and clinical trial activity in Japan and further enhances its ability to support Japanese biopharma companies as they advance programs regionally […]
Shoko Begins Commercial Production of “Viscomedi” at South Korean Plant
Shoko Co., Ltd. (Head Office: Minato-ku, Tokyo; President & CEO: Kentaro Watanabe; hereinafter “Shoko”), a comprehensive commodity trading firm engaged in three business domains—chemicals, plastics, and metal & ceramics—is pleased to announce that, following the sales framework agreement announced in June 2025 with Hannong Chemicals Inc. (Anyang, Gyeonggi-do, South Korea; hereinafter “Hannong Chemicals”), the manufacturing […]
Cartilage Tissue Engineering Study Heads to ISS
Researchers in the DELTAi Lab at the University of California, Irvine, working with NASA, are using Evercode Cell Fixation to preserve samples aboard the International Space Station as part of a study of cartilage tissue engineering in microgravity. The unprecedented work, part of a National Science Foundation (NSF)-funded grant led by Dr. Wendy Brown and Dr. Kyriacos […]
How Biotechnology Is Reshaping the Future of Wellness and Longevity
Healthcare is changing rapidly as biotechnology transforms the way people approach wellness, disease prevention, and healthy aging. Traditional healthcare systems mainly focused on treating illnesses after symptoms appeared. Today, scientific advances are shifting attention toward prevention, personalized care, and long-term health management. Biotechnology is helping people make better decisions earlier, giving individuals more control over […]
Sensorion Appoints Fred Chereau as CEO
Sensorion, a pioneering clinical-stage biotechnology company specialising in the development of novel therapies to restore, treat and prevent hearing loss disorders, on May 18th announced the appointment of Fred Chereau as Chief Executive Officer (CEO), effective June 1, 2026. Fred brings more than 30 years of leadership and operational experience across the biotechnology, pharmaceutical, and medical […]
Signadori Bio appoints Dr Selwyn Ho as CEO to drive company growth
Signadori Bio, a preclinical-stage biopharmaceutical company developing a next generation, off-the shelf, in vivo engineered, monocyte immunotherapy platform to treat solid tumours, recently announced the appointment of Dr. Selwyn Ho as Chief Executive Officer. Dr. Ho is an experienced biopharma and biotech executive, with nearly 30 years of experience across commercialisation, drug development and multiple […]
Samsung Epis Holdings Launches Its New Investment Holding as Samsung Bioepis
Samsung Epis Holdings Co., Ltd. recently announced its establishment as a new investment holding company, following the spin-off of Samsung Bioepis Co., Ltd. from Samsung Biologics (KRX: 207940.KS). Samsung Epis Holdings will be listed on Korea Exchange (KRX) on November 24, 2025, after the establishment of a new subsidiary company on November 14, 2025. Samsung […]
René Lammers Named Chief Research & Innovation Officer at Estée Lauder
The Estée Lauder Companies Inc. announced on September 11th, the appointment of René Lammers, PhD. , as Executive Vice President, Chief Research & Innovation Officer, effective October 1, 2025. Mr. Lammers will report directly to Stéphane de La Faverie, President and Chief Executive Officer, and will join the company’s Executive Team. “René is an exceptional and innovative leader […]
STEMCELL Technologies Acquires Cellular Highways Ltd
STEMCELL Technologies, one of Canada’s largest biotechnology company, is pleased to announce the acquisition of Cellular Highways Ltd from TTP Group Ltd. Cellular Highways is a biotechnology company based near Cambridge, United Kingdom, that specializes in advanced cell sorting technologies with applications in cell and gene therapy, drug discovery, and general cell research, especially where […]